Koconis John 4
4 · Timber Pharmaceuticals, Inc. · Filed Apr 19, 2022
Insider Transaction Report
Form 4
Koconis John
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2022-04-15+600,000→ 600,000 totalExercise: $0.31Exp: 2032-04-14→ Common Stock, par value $0.001 per share (600,000 underlying)
Footnotes (1)
- [F1]25% of the options vest on April 15, 2023, and the remaining shares will become exercisable in 36 equal monthly installments beginning on May 15, 2023, as long as the Reporting Person remains in continuous service with Timber Pharmaceuticals, Inc. through each vesting date.